REIT - Healthcare Facilities
Compare Stocks
4 / 10Stock Comparison
HR vs DOC vs VTR vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
HR vs DOC vs VTR vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $7.06B | $13.56B | $41.18B | $151.66B |
| Revenue (TTM) | $1.15B | $2.87B | $6.13B | $11.63B |
| Net Income (TTM) | $-201M | $222M | $260M | $1.43B |
| Gross Margin | -9.7% | 21.2% | -4.3% | 39.1% |
| Operating Margin | 19.5% | 18.3% | 13.4% | 4.4% |
| Forward P/E | — | 100.1x | 118.1x | 79.7x |
| Total Debt | $4.15B | $10.44B | $13.22B | $21.38B |
| Cash & Equiv. | $26M | $538M | $741M | $5.03B |
HR vs DOC vs VTR vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Healthcare Realty T… (HR) | 100 | 65.9 | -34.1% |
| Healthpeak Properti… (DOC) | 100 | 79.1 | -20.9% |
| Ventas, Inc. (VTR) | 100 | 247.8 | +147.8% |
| Welltower Inc. (WELL) | 100 | 427.2 | +327.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HR vs DOC vs VTR vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HR lags the leaders in this set but could rank higher in a more targeted comparison.
DOC is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 1 yrs, beta 0.52, yield 6.3%
- 6.3% yield, 1-year raise streak, vs WELL's 1.3%
VTR is the clearest fit if your priority is stability.
- Beta 0.01 vs DOC's 0.52, lower leverage
WELL carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 233.9% 10Y total return vs VTR's 66.5%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- Beta 0.13, yield 1.3%, current ratio 5.34x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs HR's -6.9% | |
| Value | Lower P/E (79.7x vs 118.1x) | |
| Quality / Margins | 12.3% margin vs HR's -17.5% | |
| Stability / Safety | Beta 0.01 vs DOC's 0.52, lower leverage | |
| Dividends | 6.3% yield, 1-year raise streak, vs WELL's 1.3% | |
| Momentum (1Y) | +45.8% vs DOC's +18.8% | |
| Efficiency (ROA) | 2.3% ROA vs HR's -2.1%, ROIC 0.5% vs 0.7% |
HR vs DOC vs VTR vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HR vs DOC vs VTR vs WELL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
WELL leads in 3 of 6 categories
DOC leads 1 • HR leads 0 • VTR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 10.1x HR's $1.1B. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to HR's -17.5%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $2.9B | $6.1B | $11.6B |
| EBITDAEarnings before interest/tax | $767M | $1.6B | $2.3B | $2.8B |
| Net IncomeAfter-tax profit | -$201M | $222M | $260M | $1.4B |
| Free Cash FlowCash after capex | $201M | $1.2B | $1.4B | $2.5B |
| Gross MarginGross profit ÷ Revenue | -9.7% | +21.2% | -4.3% | +39.1% |
| Operating MarginEBIT ÷ Revenue | +19.5% | +18.3% | +13.4% | +4.4% |
| Net MarginNet income ÷ Revenue | -17.5% | +7.7% | +4.2% | +12.3% |
| FCF MarginFCF ÷ Revenue | +17.5% | +40.2% | +22.4% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -10.5% | +7.1% | +22.0% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.8% | +3.6% | 0.0% | +22.5% |
Valuation Metrics
DOC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 155.7x trailing earnings, WELL trades at a 20% valuation discount to DOC's 195.0x P/E. On an enterprise value basis, DOC's 14.6x EV/EBITDA is more attractive than WELL's 67.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $7.1B | $13.6B | $41.2B | $151.7B |
| Enterprise ValueMkt cap + debt − cash | $11.2B | $23.5B | $53.7B | $168.0B |
| Trailing P/EPrice ÷ TTM EPS | -28.51x | 195.00x | 160.41x | 155.73x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 100.10x | 118.12x | 79.69x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 16.97x | 14.64x | 24.33x | 67.37x |
| Price / SalesMarket cap ÷ Revenue | 5.98x | 4.80x | 7.06x | 14.22x |
| Price / BookPrice ÷ Book value/share | 1.51x | 1.63x | 3.18x | 3.40x |
| Price / FCFMarket cap ÷ FCF | 55.62x | 11.82x | 31.28x | 53.25x |
Profitability & Efficiency
WELL leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-4 for HR. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to DOC's 1.26x. On the Piotroski fundamental quality scale (0–9), HR scores 7/9 vs DOC's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.3% | +2.6% | +2.1% | +3.5% |
| ROA (TTM)Return on assets | -2.1% | +1.1% | +1.0% | +2.3% |
| ROICReturn on invested capital | +0.7% | +2.3% | +2.5% | +0.5% |
| ROCEReturn on capital employed | +1.0% | +2.8% | +3.2% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.89x | 1.26x | 1.05x | 0.49x |
| Net DebtTotal debt minus cash | $4.1B | $9.9B | $12.5B | $16.3B |
| Cash & Equiv.Liquid assets | $26M | $538M | $741M | $5.0B |
| Total DebtShort + long-term debt | $4.1B | $10.4B | $13.2B | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | -0.21x | 1.78x | 1.40x | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,193 today (with dividends reinvested), compared to $8,393 for DOC. Over the past 12 months, WELL leads with a +45.8% total return vs DOC's +18.8%. The 3-year compound annual growth rate (CAGR) favors WELL at 43.3% vs DOC's 3.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +20.8% | +22.9% | +12.7% | +16.2% |
| 1-Year ReturnPast 12 months | +40.0% | +18.8% | +34.6% | +45.8% |
| 3-Year ReturnCumulative with dividends | +18.7% | +11.3% | +94.4% | +194.0% |
| 5-Year ReturnCumulative with dividends | +3.8% | -16.1% | +77.4% | +211.9% |
| 10-Year ReturnCumulative with dividends | +41.5% | +15.3% | +66.5% | +233.9% |
| CAGR (3Y)Annualised 3-year return | +5.9% | +3.6% | +24.8% | +43.3% |
Risk & Volatility
Evenly matched — DOC and VTR each lead in 1 of 2 comparable metrics.
Risk & Volatility
VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than DOC's 0.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.13x | 0.52x | 0.01x | 0.13x |
| 52-Week HighHighest price in past year | $20.46 | $19.68 | $88.50 | $219.59 |
| 52-Week LowLowest price in past year | $14.09 | $15.70 | $61.76 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +98.9% | +99.1% | +97.9% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 75.1 | 48.4 | 57.0 | 57.6 |
| Avg Volume (50D)Average daily shares traded | 3.5M | 8.0M | 3.4M | 2.6M |
Analyst Outlook
Evenly matched — DOC and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HR as "Hold", DOC as "Buy", VTR as "Buy", WELL as "Buy". Consensus price targets imply 4.8% upside for VTR (target: $91) vs -8.4% for DOC (target: $18). For income investors, DOC offers the higher dividend yield at 6.26% vs WELL's 1.28%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $19.33 | $17.86 | $90.80 | $226.50 |
| # AnalystsCovering analysts | 29 | 40 | 32 | 34 |
| Dividend YieldAnnual dividend ÷ price | +5.5% | +6.3% | +2.1% | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 1 | 1 | 2 |
| Dividend / ShareAnnual DPS | $1.11 | $1.22 | $1.86 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +0.7% | 0.0% | 0.0% |
WELL leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DOC leads in 1 (Valuation Metrics). 2 tied.
HR vs DOC vs VTR vs WELL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HR or DOC or VTR or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -6. 9% for Healthcare Realty Trust Incorporated (HR). Welltower Inc. (WELL) offers the better valuation at 155. 7x trailing P/E (79. 7x forward), making it the more compelling value choice. Analysts rate Healthpeak Properties, Inc. (DOC) a "Buy" — based on 40 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HR or DOC or VTR or WELL?
On trailing P/E, Welltower Inc.
(WELL) is the cheapest at 155. 7x versus Healthpeak Properties, Inc. at 195. 0x. On forward P/E, Welltower Inc. is actually cheaper at 79. 7x.
03Which is the better long-term investment — HR or DOC or VTR or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +211. 9%, compared to -16. 1% for Healthpeak Properties, Inc. (DOC). Over 10 years, the gap is even starker: WELL returned +233. 9% versus DOC's +15. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HR or DOC or VTR or WELL?
By beta (market sensitivity over 5 years), Ventas, Inc.
(VTR) is the lower-risk stock at 0. 01β versus Healthpeak Properties, Inc. 's 0. 52β — meaning DOC is approximately 5359% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 126% for Healthpeak Properties, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HR or DOC or VTR or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -6. 9% for Healthcare Realty Trust Incorporated (HR). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -72. 2% for Healthpeak Properties, Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HR or DOC or VTR or WELL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -20. 8% for Healthcare Realty Trust Incorporated — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOC leads at 19. 3% versus 3. 3% for WELL. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HR or DOC or VTR or WELL more undervalued right now?
On forward earnings alone, Welltower Inc.
(WELL) trades at 79. 7x forward P/E versus 118. 1x for Ventas, Inc. — 38. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VTR: 4. 8% to $90. 80.
08Which pays a better dividend — HR or DOC or VTR or WELL?
All stocks in this comparison pay dividends.
Healthpeak Properties, Inc. (DOC) offers the highest yield at 6. 3%, versus 1. 3% for Welltower Inc. (WELL).
09Is HR or DOC or VTR or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +233. 9% 10Y return). Both have compounded well over 10 years (WELL: +233. 9%, DOC: +15. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HR and DOC and VTR and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HR is a small-cap income-oriented stock; DOC is a mid-cap income-oriented stock; VTR is a mid-cap high-growth stock; WELL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.